The round was joined by Chinese TMT and healthcare-focused investment company Cowin Venture, Yahui Precision Medicine Fund and Matrix Partners China. The post Matrix-backed Chinese biotech startup Genecast closes $43m Series D1 round appeared first on DealStreetAsia.